Evolent registers 8.47M common shares and shares underlying preferred for resale

Evolent Health, Inc.

Filed prospectus supplement for resale of up to 8,474,576 common shares issued Jan. 20, 2023 to Magellan Health in NIA Acquisition.
Separate prospectus supplement for resale of up to 4,375,000 common shares issuable on conversion of 175,000 Series A Preferred shares.
Shares already issued; filing relates to registration for secondary resale by selling stockholders.
Legal opinions from King & Spalding LLP filed as exhibits 5.1 and 5.2.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.